Kristina Burow
CIK: 0001569248
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- Jul 1, 2026SRRK
Scholar Rock Holding Corp
Sale(S)Direct948 shares at avg. $54.28$51K - Jul 1, 2026SRRK
Scholar Rock Holding Corp
Sale(S)Direct2.1K shares at avg. $53.49$113K - Jun 4, 2026SRRK
Scholar Rock Holding Corp
Award(A)Direct6.8K shares- - May 27, 2026NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
80K shares- - Apr 23, 2026SRRK
Scholar Rock Holding Corp
Exercise(M)Direct36K shares at avg. $9.11$328K - Apr 23, 2026SRRK
Scholar Rock Holding Corp
Exercise(M)Direct18K shares at avg. $8.36$150K - Apr 23, 2026SRRK
Scholar Rock Holding Corp
Exercise(M)Direct7.8K shares at avg. $26.78$209K - Apr 23, 2026SRRK
Scholar Rock Holding Corp
Exercise(M)Direct28K shares at avg. $4.75$133K - Nov 13, 2025MTSR
Metsera, Inc.
Disposition(D)Indirect17.1M shares- - Nov 13, 2025MTSR
Metsera, Inc.
Disposition(D)Indirect7.5M shares- - Nov 13, 2025MTSR
Metsera, Inc.
Disposition(D)Indirect8.3M shares- - Nov 13, 2025MTSR
Metsera, Inc.
Disposition(D)Direct2.7K shares- - Nov 13, 2025MTSR
Metsera, Inc.
Disposition(D)Indirect18.5M shares- - Nov 13, 2025MTSR
Metsera, Inc.
Award(A)DirectRestricted Stock Unit
2.7K shares- - Oct 27, 2025NMRA
Neumora Therapeutics, Inc.
Purchase(P)Indirect1.9M shares at avg. $2.61$5.0M - Jun 23, 2025BOLD
Boundless Bio, Inc.
Award(A)DirectStock Option (right to buy)
16K shares- - May 29, 2025SRRK
Scholar Rock Holding Corp
Sale(S)Direct4.4K shares at avg. $29.83$131K - May 29, 2025SRRK
Scholar Rock Holding Corp
Sale(S)Direct1K shares at avg. $29.24$29K - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
80K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
46.5K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
28.6K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
46.5K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
28.6K shares- - May 22, 2025SRRK
Scholar Rock Holding Corp
Award(A)Direct7.6K shares- - May 20, 2025MTSR
Metsera, Inc.
Award(A)DirectStock Option (Right to Buy)
16.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 |  SRRK Scholar Rock Holding Corp | Sale(S) | 948 | $54.28 | $51,459 | Direct |
| Jul 1, 2026 | SRRK Scholar Rock Holding Corp | Sale(S) | 2,105 | $53.49 | $112,605 | Direct |
| Jun 4, 2026 | SRRK Scholar Rock Holding Corp | Award(A) | 6,839 | - | $0 | Direct |
| May 27, 2026 |  NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 80,000 | - | - | Direct |
| Apr 23, 2026 | SRRK Scholar Rock Holding Corp | Exercise(M) | 36,000 | $9.11 | $327,960 | Direct |
| Apr 23, 2026 | SRRK Scholar Rock Holding Corp | Exercise(M) | 18,000 | $8.36 | $150,480 | Direct |
| Apr 23, 2026 | SRRK Scholar Rock Holding Corp | Exercise(M) | 7,800 | $26.78 | $208,884 | Direct |
| Apr 23, 2026 | SRRK Scholar Rock Holding Corp | Exercise(M) | 28,000 | $4.75 | $133,000 | Direct |
| Nov 13, 2025 |  MTSR Metsera, Inc. | Disposition(D) | 17,070,904 | - | - | Indirect |
| Nov 13, 2025 | MTSR Metsera, Inc. | Disposition(D) | 7,523,682 | - | - | Indirect |
| Nov 13, 2025 | MTSR Metsera, Inc. | Disposition(D) | 8,313,680 | - | - | Indirect |
| Nov 13, 2025 | MTSR Metsera, Inc. | Disposition(D) | 2,688 | - | - | Direct |
| Nov 13, 2025 | MTSR Metsera, Inc. | Disposition(D) | 18,503,128 | - | - | Indirect |
| Nov 13, 2025 | MTSR Metsera, Inc. | Award(A) Restricted Stock Unit | 2,688 | - | - | Direct |
| Oct 27, 2025 | NMRA Neumora Therapeutics, Inc. | Purchase(P) | 1,915,700 | $2.61 | $4,999,977 | Indirect |
| Jun 23, 2025 |  BOLD Boundless Bio, Inc. | Award(A) Stock Option (right to buy) | 16,000 | - | - | Direct |
| May 29, 2025 | SRRK Scholar Rock Holding Corp | Sale(S) | 4,400 | $29.83 | $131,269 | Direct |
| May 29, 2025 | SRRK Scholar Rock Holding Corp | Sale(S) | 1,000 | $29.24 | $29,242 | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 80,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 46,455 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 28,571 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 46,455 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 28,571 | - | - | Direct |
| May 22, 2025 | SRRK Scholar Rock Holding Corp | Award(A) | 7,632 | - | - | Direct |
| May 20, 2025 | MTSR Metsera, Inc. | Award(A) Stock Option (Right to Buy) | 16,125 | - | - | Direct |
1-25 of 33 transactions
About Burow Kristina
Burow Kristina (SEC CIK 0001569248) files insider reports with the SEC as Director of Scholar Rock Holding Corp (SRRK), Director of Neumora Therapeutics, Inc. (NMRA) and Director of Metsera, Inc. (MTSR). Signal8 also holds filings tied to 1 other company.
Signal8 holds 14 ownership filings by Burow Kristina (1 Form 3, 13 Form 4), filed between Jan 30, 2025 and Jul 6, 2026. Those filings report 33 transactions, from Feb 3, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Burow Kristina's filings is in CAMBRIDGE, MA.
Recent filings by Burow Kristina
- Jul 1, 2026: Open-market sales of SRRK shares (2 lines, Form 4, code S).
- Jun 4, 2026: Grant or award of SRRK shares (Form 4, code A).
- May 27, 2026: Grant or award of NMRA derivative securities (Form 4, code A).
- Apr 23, 2026: Option exercises of SRRK shares (4 lines, Form 4, code M).
- Nov 13, 2025: Disposition to issuer transactions of MTSR shares (5 lines, Form 4, code D).
Other insiders filing for Scholar Rock Holding Corp (SRRK)
- AKKARAJU SRINIVAS, Director
- Woods Keith, Chief Operating Officer
- Hallal David, Chief Executive Officer
- FLIER JEFFREY S., Director
- Gilman Michael, Director
- Reed Joshua, Director